EUVIMEDEUVIMED entdecken
Crossref

Contingency Management for the Treatment of Stimulant Use Disorder

Amy J Kennedy, Elenore P Bhatraju, Brian Chan

JAMA Internal Medicine · 01.07.2026 · 186 (7) · 892

DOI: 10.1001/jamainternmed.2026.1163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Internal Medicine, erschienen am 01.07.2026. Verfasst von Amy J Kennedy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Internal Medicine, University of Washington School of Medicine, VA Puget Sound Health Care System, Seattle. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Clinical Insights discusses the use of contingency management for the treatment of stimulant use disorder.

Autor:innen und Institutionen

  • Division of General Internal Medicine, University of Washington School of Medicine, VA Puget Sound Health Care System, Seattle.
  • University of Washington School of Medicine, Harborview Medical Center, Seattle.
  • Oregon Health and Science University, Portland.

Zitieren

APA

Kennedy, A. J., Bhatraju, E. P., & Chan, B. (2026). Contingency Management for the Treatment of Stimulant Use Disorder. JAMA Internal Medicine, 186(7), 892. https://doi.org/10.1001/jamainternmed.2026.1163

Vancouver

Kennedy AJ, Bhatraju EP, Chan B. Contingency Management for the Treatment of Stimulant Use Disorder. JAMA Internal Medicine. 2026;186(7):892. doi:10.1001/jamainternmed.2026.1163

BibTeX
@article{Kennedy2026,
  author = {Kennedy, Amy J and Bhatraju, Elenore P and Chan, Brian},
  title = {Contingency Management for the Treatment of Stimulant Use Disorder},
  journal = {JAMA Internal Medicine},
  year = {2026},
  volume = {186},
  number = {7},
  pages = {892},
  doi = {10.1001/jamainternmed.2026.1163}
}
Kostenlos starten →